Bibliography
- Selkoe DJ : The molecular pathology of Alzheimer‘s disease.Neuron6 , 487–498 (1991).
- Chertkow H , BergmanH, SchipperHM et al.: Assessment of suspected dementia. Can. J. Neurol. Sci.28(Suppl.1) , S28–S41 (2001).
- Consensus report of the Working Group on: ’Molecular and Biochemical Markers of Alzheimer‘s Disease.‘ The Ronald and Nancy Reagan Research Institute of the Alzheimer‘s Association and the National Institute on Aging Working Group. Neurobiol. Aging19 , 109–116 (1998).
- Bailey P : Biological markers in Alzheimer‘s disease.Can. J. Neurol. Sci.34(Suppl.1) , S72–S76 (2007).
- Chertkow H , BlackS: Imaging biomarkers and their role in dementia clinical trials.Can. J. Neurol. Sci.34(Suppl. 1) , S77–S83 (2007).
- Choe LH , DuttMJ, RelkinN, LeeKH: Studies of potential cerebrospinal fluid molecular markers for Alzheimer‘s disease.Electrophoresis23 , 2247–2251 (2002).
- Dennery PA : Regulation and role of heme oxygenase in oxidative injury.Curr. Top. Cell Regul.36 , 181–199 (2000).
- Schipper HM : Heme oxygenase expression in human central nervous system disorders.Free Radic. Biol. Med.37 , 1995–2011 (2004).
- Lavrovsky Y : Drummond GS, Abraham NG: Downregulation of the human heme oxygenase gene by glucocorticoids and identification of 56b regulatory elements.Biochem. Biophys. Res. Commun.218 , 759–765 (1996).
- Kitamuro T , TakahashiK, OgawaK et al.: Bach1 functions as a hypoxia-inducible repressor for the heme oxygenase-1 gene in human cells. J. Biol. Chem.278 , 9125–9133 (2003).
- Stocker R , YamamotoY, McDonaghAF, GlazerAN, AmesBN: Bilirubin is an antioxidant of possible physiological importance.Science235 , 1043–1046 (1987).
- Song W , SuH, SongS, PaudelHK, SchipperHM: Over-expression of heme oxygenase-1 promotes oxidative mitochondrial damage in rat astroglia.J. Cell Physiol.206 , 655–663 (2006).
- Zhang J , PiantadosiCA: Mitochondrial oxidative stress after carbon monoxide hypoxia in the rat brain.J. Clin. Invest.90 , 1193–1199 (1992).
- Schipper HM , CisseS, StopaEG: Expression of heme oxygenase-1 in the senescent and Alzheimer-diseased brain.Ann. Neurol.37 , 758–768 (1995).
- Smith MA , KuttyRK, RicheyPL et al.: Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer‘s disease. Am. J. Pathol.145 , 42–47 (1994).
- Schipper HM , BennettDA, LibermanA et al.: Glial heme oxygenase-1 expression in Alzheimer‘s disease and mild cognitive impairment. Neurobiol. Aging27 , 252–261 (2006).
- Ham D , SchipperHM: Heme oxygenase-1 induction and mitochondrial iron sequestration in astroglia exposed to amyloid peptides.Cell. Mol. Biol. (Noisy-le-grand)46 , 587–596 (2000).
- Mehindate K , SahlasDJ, FrankelD et al.: Proinflammatory cytokines promote glial heme oxygenase-1 expression and mitochondrial iron deposition: implications for multiple sclerosis. J. Neurochem.77 , 1386–1395 (2001).
- Schipper HM : Brain iron deposition and the free radical-mitochondrial theory of ageing.Ageing Res. Rev.3 , 265–301 (2004).
- Schipper HM , BernierL, MehindateK, FrankelD: Mitochondrial iron sequestration in dopamine-challenged astroglia: role of heme oxygenase-1 and the permeability transition pore.J. Neurochem.72 , 1802–1811 (1999).
- Schipper HM : In: Redox-Active Metals in Neurological Disorders. LeVine S, Connor JR, Schipper HM (Eds). New York Academy of Sciences, NY, USA, 84–93 1012 (2004).
- Schipper HM , ChertkowH, MehindateK, FrankelD, MelmedC, BergmanH: Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD.Neurology54 , 1297–1304 (2000).
- Anthony SG , SchipperHM, TavaresR et al.: Stress protein expression in the Alzheimer-diseased choroid plexus. J. Alzheimers Dis.5 , 171–177 (2003).
- Ishizuka K , KimuraT, YoshitakeJ et al.: Possible assessment for antioxidant capacity in Alzheimer‘s disease by measuring lymphocyte heme oxygenase-1 expression with real-time RT-PCR. NY Acad. Sci.977 , 173–178 (2002).
- Schipper HM , MawalY, ChertkowH, BergmanH: Blood HO-1 mRNA in AD and MCI.Neurology57 , 2142–2143 (2001).
- Maes OC , XuS, YuB, ChertkowHM, WangE, SchipperHM: Transcriptional profiling of Alzheimer blood mononuclear cells by microarray.Neurobiol. Aging28 , 1795–1809 (2007).
- Nunomura A , PerryG, PappollaMA et al.: RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer‘s disease. J. Neurosci.19 , 1959–1964 (1999).
- Mecocci P , PolidoriMC, IngegniT et al.: Oxidative damage to DNA in lymphocytes from AD patients. Neurology51 , 1014–1017 (1998).
- Morocz M , KalmanJ, JuhaszA et al.: Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer‘s disease. Neurobiol. Aging23 , 47–53 (2002).
- Kimpara T , TakedaA, WatanabeK et al.: Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease. Hum. Genet.100 , 145–147 (1997).
- Maes OC , KravitzS, MawalY et al.: Characterization of α(1)-antitrypsin as a heme oxygenase-1 suppressor in Alzheimer plasma. Neurobiol. Dis.24 , 89–100 (2006).
- Chopra VS , ChalifourLE, SchipperHM: Differential effects of cysteamine on heat shock protein induction and cytoplasmic granulation in astrocytes and glioma cells.Brain Res. Mol. Brain Res.31 , 173–184 (1995).
- Balldin J , GottfriesCG, KarlssonI, LindstedtG, LangstromG, WalinderJ: Dexamethasone suppression test and serum prolactin in dementia disorders.Br. J. Psychiatry143 , 277–281 (1983).
- Spar JE , GernerR: Does the dexamethasone suppression test distinguish dementia from depression?Am. J. Psychiatry139 , 238–240 (1982).
- Yu HL , ChertkowHM, BergmanH, SchipperHM: Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma.Proteomics3 , 2240–2248 (2003).
- Dik MG , JonkerC, HackCE, SmitJH, ComijsHC, EikelenboomP: Serum inflammatory proteins and cognitive decline in older persons.Neurology64 , 1371–1377 (2005).
- Gabriel SM , MarinDB, AisenPS et al.: Association of elevated α1-antichymotrypsin with cognitive impairment in a prospective study of the very old. Am. J. Psychiatry155 , 698–700 (1998).
- Licastro F , PedriniS, CaputoL et al.: Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer‘s disease: peripheral inflammation or signals from the brain? J. Neuroimmunol.103 , 97–102 (2000).
- Licastro F , PedriniS, DavisLJ et al.: α-1-antichymotrypsin and oxidative stress in the peripheral blood from patients with probable Alzheimer‘s disease: a short-term longitudinal study. Alzheimer Dis. Assoc. Disord.15 , 51–55 (2001).
- Scacchi R , RuggeriM, GambinaG, MartiniMC, FerrariG, CorboRM: Plasma α1-antichymotrypsin in Alzheimer‘s disease; relationships with APOEgenotypes. Neurobiol. Aging22 , 413–416 (2001).
- Churg A , DaiJ, ZayKet al.: α-1-antitrypsin and a broad spectrum metalloprotease inhibitor, RS113456, have similar acute anti-inflammatory effects. Lab. Invest.81 , 1119–1131 (2001).
- Gollin PA , KalariaRN, EikelenboomP, RozemullerA, PerryG: α 1-antitrypsin and α 1-antichymotrypsin are in the lesions of Alzheimer‘s disease.Neuroreport3 , 201–203 (1992).
- Puchades M , HanssonSF, NilssonCL, AndreasenN, BlennowK, DavidssonP: Proteomic studies of potential cerebrospinal fluid protein markers for Alzheimer‘s disease.Brain Res. Mol. Brain Res.118 , 140–146 (2003).
- Bohrmann B , TjernbergL, KunerPet al.: Endogenous proteins controlling amyloid β-peptide polymerization. Possible implications for β-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem.274 , 15990–15995 (1999).
- Abraham CR : Reactive astrocytes and α1-antichymotrypsin in Alzheimer‘s disease.Neurobiol. Aging22 , 931–936 (2001).
- Sun YX , MinthonL, WallmarkA, WarkentinS, BlennowK, JanciauskieneS: Inflammatory markers in matched plasma and cerebrospinal fluid from patients with Alzheimer‘s disease. Dement. Geriatr. Cogn. Disord.16 , 136–144 (2003).